All Events
Age related Macular Degeneration: What's on the Horizon

27/02/2025

18:30 - 19:30

CPD Points For Attending This Event: 1

Webinar

This event has already taken place.

Age-related macular degeneration (AMD) advances through early, intermediate, and late stages. While anti-VEGF therapies are effective for wet AMD, there are no approved treatments currently available for dry AMD in the UK. Emerging approaches, including sustained-release anti-VEGF, gene therapy, and complement inhibitors, offer hope for dry AMD.

Slides available here

 

Speakers

Dr. Yasmine Abdallah, M.S, FRCOphth.,

Consultant Ophthalmologist, Uveitis Service Lead, University Hospitals of Derby and Burton NHS Trust. U.K.

The webinar was presented by Dr. Yasmine Abdalla, Consultant Ophthalmologist. Dr. Abdalla is the Uveitis Service Lead at the University Hospitals of Derby and Burton NHS Foundation Trust, and is a fellow of the Royal College of Ophthalmologists.

Topics

AMD - Definition Drusen Types of Drusen Soft Drusen Cuticular Drusen Sub-retinal drusenoid deposits Prevalence Risk factors Beckman classification Stages of Dry AMD - AREDS Grading System Prognostic factors 2023 Euretina clinical trends survey Diagnosis A.I in AMD Assessing AMD Microperimetry OCT CAM Classification system Treatment - Dry AMD Syfovre (pegcetacoplan) Izervay (avacincaptad) Photobiomodulation Neo-vascular AMD GASS Classification of CNV Treatment - Antivegf Avastin Lucentis Eyelea Faricimab Brolucizumab Ranibizumab Faricimab Aflibercept Port delivery system - Ranibizumab Zifibancimig Intravitreal drug delivery implants - Axitinib Vorolanib Suprachoroidal drug delivery - CLS AX Axitinib phase 2 ODYSSEY Subretinal drug delivery via PPV Gene therapy Stereotactic radiotherapy

The webinar is accredited for 1 CPD point for Optometrists and Ophthalmologist

Sponsors

Other Events

How do we minimise stents in Coronary intervention? Drug coated balloons: Emerging and Expanding Indications

24/04/2025 - 18:30 - 19:30

Rated Doctor